This inventor holds 1 USPTO granted patent. Top assignee: Ici Americas, Inc.. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Scott H Bergeson: Innovator in Peptide Derivatives
Introduction
Scott H Bergeson is a notable inventor based in Wilmington, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on peptide derivatives. His research focuses on developing compounds that have potential therapeutic applications.
Latest Patents
Scott H Bergeson holds a patent for his invention related to peptide derivatives. The patent describes pharmaceutically useful trifluoromethyl ketone substituted di-, tri-, and tetra-peptide derivatives, which are inhibitors of human leukocyte elastase. This invention includes pharmaceutical compositions containing these peptide derivatives, as well as processes and intermediates for their manufacture.
Career Highlights
Bergeson is associated with Ici Americas, Inc., where he has been able to apply his expertise in peptide chemistry. His work has contributed to advancements in pharmaceutical formulations and therapeutic strategies.
Collaborations
Throughout his career, Scott has collaborated with notable colleagues, including Philip D Edwards and John A Schwartz. These collaborations have enhanced the scope and impact of his research.
Conclusion
Scott H Bergeson is a distinguished inventor whose work on peptide derivatives has the potential to influence pharmaceutical development significantly. His contributions reflect a commitment to innovation in the field of medicine.